QLYS Form 4: Director John Zangardi disposes of 3,103 shares at ~$134.94
Rhea-AI Filing Summary
John A. Zangardi, a director of Qualys, Inc. (QLYS), sold 3,103 shares of the company's common stock on 08/27/2025 at a weighted average price of $134.9405 per share, with individual sale prices ranging from $134.50 to $135.46. After the sale, Mr. Zangardi beneficially owned 4,071 shares directly and 5 shares indirectly through his son. The Form 4 was filed as an individual filing and signed under power of attorney by Bruce Posey on 08/29/2025.
Positive
- Filing contains full transaction details including sale quantity, weighted average price, price range, transaction date, and post-transaction ownership
- Reporting person remains a company insider (identified as a director), and retains ownership after the sale
Negative
- Insider sale disclosed: director sold 3,103 shares on 08/27/2025, which may be interpreted negatively by some investors
Insights
TL;DR: Director sold a modest block of shares; ownership remains small and largely unchanged.
The Form 4 shows a single non-derivative sale of 3,103 common shares by director John A. Zangardi on 08/27/2025 at a weighted average price of $134.9405 per share. Post-transaction beneficial ownership is 4,071 shares directly and 5 shares indirectly via his son, indicating the director retains a position but it is not large in absolute terms as disclosed. The filing was signed via power of attorney by Bruce Posey on 08/29/2025. For investors, this is a routine insider sale disclosure without additional context on intent or further transactions.
TL;DR: Disclosure is complete for the reported transaction; no governance red flags in the form.
The Form 4 discloses the required details: reporting person identity, relationship (director), transaction date, transaction code (S for sale), number of shares sold (3,103), sale price range ($134.50–$135.46), and resulting beneficial ownership (4,071 direct, 5 indirect). The document is signed under power of attorney. There are no indications of coordinated filings or unusual reporting delays in the text provided. The filing meets Section 16 disclosure elements shown here.